Navigation Links
Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
Date:2/3/2009

Therapeutic Approach Provides HIV-Resistant Immune Cells

RICHMOND, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that its collaborators at the University of Pennsylvania have opened a Phase 1 clinical trial to evaluate SB-728-T for the treatment of HIV/AIDS.

Based on Sangamo's zinc finger DNA-binding protein nuclease (ZFN) technology, SB-728-T has been shown in an animal model of HIV infection to lead to an increase in CD4+ T-cell counts, a reduction in viral load and expansion of CCR5-modified T-cells, suggesting resistance to HIV.

"This is the first time that we have had the ability to make a patient's T-cells permanently resistant to infection by CCR5-specific strains of HIV and we are very excited to begin a clinical trial of this novel ZFN-based therapy," said Carl June, M.D., Director of Translational Research at the Abramson Family Cancer Research Institute at the University of Pennsylvania School of Medicine. "The ability to protect immune cells from infection with HIV and the expansion of CCR5-modified T-cells has the potential to provide long-term control of both the virus itself and eventually the opportunistic infections characteristic of AIDS."

CCR5 is a co-receptor that enables HIV to enter and infect cells of the immune system. About ten years ago, it was observed that individuals carrying a natural mutation of their CCR5 gene, CCR5-delta32, were highly resistant to infection by HIV. These individuals, lacking a functional CCR5 (approximately 1-2% of the general population), are immunologically "normal". A variety of small molecule and antibody antagonists of CCR5 binding have been tested and developed as potential therapeutic agents for the treatment of HIV infection. In addition, there is a recent report
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
2. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
3. Sangamo BioSciences to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
5. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
6. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
7. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
8. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
9. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
10. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
11. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Quorum Review IRB, the industry leader in central IRB ... Quick Step™ . The offering went live on July ... need for seamless study start-up with a large volume of ... 50 or more North American investigator sites, as well as ... of 80 or more. Qualifying studies may also enroll international ...
(Date:7/22/2014)... Los Angeles, CA (PRWEB) July 22, 2014 ... rapid test solutions with the debut of its ... Association of Clinical Chemistry (AACC) meeting in Chicago, ... based or bench top versions, the HRDR-300 is ... patent pending technology to analyze fluorescent lateral flow ...
(Date:7/22/2014)... Lawrence, KS (PRWEB) July 22, 2014 ... as attention-deficit hyperactivity disorder (ADHD) is diagnosed, selecting medication ... trial and error. Analyzing brain patterns by using electroencephalography ... best result and thus lower the risk of adverse ... Electroencephalography Phenotypes and Biomarkers” in the current issue ...
(Date:7/22/2014)... Greenville, SC (PRWEB) July 22, 2014 ... chorus of those who have recognized that the greatest ... inefficient, and far too often needlessly deadly while trying ... the multitude of quasi-experts seeking to transform an enormous ... detail.” , Dr. Williams, in his continuing series of ...
Breaking Biology Technology:Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2
... Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader ... President Deborah Jenkins Hutchinson, will present a corporate update ... June 23, 2011 at 10 am EDT  held at ... New York City. The presentation will be webcast live ...
... 2011 Five exceptional oncology nurses out of ... Solutions | US Oncology for their dedication ... Excellence in Oncology Nursing Award honors those nurses in the ... courage and determination in providing the highest quality oncology nursing ...
... BASEL, Switzerland, June 22, 2011 The Roche manuscript: ... Production of Bispecific IgG Antibodies" has been published in ... of the USA (PNAS). Corresponding authors are ... at Penzberg, and Christian Klein, Head of Oncology Programs, ...
Cached Biology Technology:Wound Management Technologies' Webcasting Live from OneMedForum NY Biotech Conference on Thursday, June 23 at 10 am EDT 2Wound Management Technologies' Webcasting Live from OneMedForum NY Biotech Conference on Thursday, June 23 at 10 am EDT 3McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 2McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 3McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 4Proceedings of the National Academy of Sciences (PNAS) Publishes Roche Manuscript on Production of Bispecific IgG Antibodies 2
(Date:7/22/2014)... 22, 2014 BGI Tech Solutions Co., LTD, ... largest genomics organization, announced today the global launch ... based on Complete Genomics, industry-leading platform. This newly ... validation, and is available at reduced prices until ... regarded in the industry for providing proprietary sequencing ...
(Date:7/22/2014)... BOSTON -- Open a child,s lunch box and you,re likely ... of federal guidelines. Those are the findings of a study ... and Policy at Tufts University and in the Department of ... Medicine. The findings are published online ahead of print ... Dietetics . , Led by senior author Jeanne Goldberg, ...
(Date:7/21/2014)... of a multinational, collaborative effort, researchers from Canada,s Centre ... over 100 locations in the human genome associated with ... largest genomic study published on any psychiatric disorder to ... point to biological mechanisms and pathways that may underlie ... the disorder, which has seen little innovation in drug ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2Room for improvement in elementary school children's lunches and snacks from home 2International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3
... Partner -- CHANTILLY, Virginia, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... The most widely adopted measure for assessing the state of ... nearly half the ecosystems where it was applied according to ... of Washington fisheries scientist. "Applied to individual ecosystems it,s like ... answer and half the time you get the wrong answer," ...
... spring into action to begin repairing muscle damaged in a ... found that a protein naturally produced in the body may ... the right dose of this protein named secreted frizzled related ... heart failure and reduce collagen layering that can form thick ...
Cached Biology News:The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 2The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 3The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 4The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 5The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 6The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 7The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 8The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 9Scientists question indicator of fisheries health, evidence for 'fishing down food webs' 2Scientists question indicator of fisheries health, evidence for 'fishing down food webs' 3A stem cell secreted protein can be given to improve heart function after experimental heart attack 2
Request Info...
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...
...
Biology Products: